Literature DB >> 26987325

Lung Cancer and Multiple Neoplasms: A Retrospective Analysis.

A Romaszko1, E Świetlik2, A Doboszyńska2, P Szpruch3, J Luks4.   

Abstract

Over the past 30 years there has been an increase in the survival of cancer patients resulting from the advances in cancer management and improved detection of cancer in its early stages. The aim of the study was to analyze the frequency of multiple malignancies in a sample of hospitalized patients in Poland. We analyzed retrospectively the records of 1112 cancer patients hospitalized in the period of January 2013 - August 2014. The criterion for inclusion into the group of multiple malignancy patients was the presence of at least two different malignancies. We found 52 cases in which lung cancer accompanied different malignancies and 4 cases where the multiple malignancy was not associated with the respiratory system. Lung cancer was chronologically the first malignancy unravelled in 11 patients, the second in 39, and the third in 2. Other malignancies chronologically being the first to be unravelled in patients included the following: colorectal cancer in 8 patients, prostatic cancer in 6, renal cell carcinoma 4, and the subsequent: prostate cancer 4, bladder cancer 3, hematopoietic malignancies 3, and breast cancer 2. We conclude that patients with multiple malignancy account for 5.0 % of lung cancer patients. Lung cancer is more frequent as a second malignancy developing in patients with multiple malignancy. Synchronous cancers become apparent at older age than metachronous cancers.

Entities:  

Keywords:  Investigation; Malignancy; Pulmonology; Survey

Mesh:

Year:  2016        PMID: 26987325     DOI: 10.1007/5584_2016_224

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Evidence-based nursing intervention can improve the treatment compliance, quality of life and self-efficacy of patients with lung cancer undergoing radiotherapy and chemotherapy.

Authors:  Tianjie Zhang; Jierong Lu; Yanmei Fan; Li Wang
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

2.  P53 Regulation-Association Long Non-Coding RNA (LncRNA PRAL) Inhibits Cell Proliferation by Regulation of P53 in Human Lung Cancer.

Authors:  Pengxiao Su; Fengqin Wang; Bin Qi; Ting Wang; Shaobo Zhang
Journal:  Med Sci Monit       Date:  2017-04-11

3.  Application Value of Evidence-Based Care in Patients with Lung Cancer Chemotherapy.

Authors:  Ying Chen; Hong Xu; Yun Cheng; Yuan Qian
Journal:  Comput Math Methods Med       Date:  2022-07-30       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.